Bausch Health Cos Change in Accounts Receivable 2010-2024 | BHC
Bausch Health Cos change in accounts receivable from 2010 to 2024. Change in accounts receivable can be defined as the increase or decrease in accounts receivable for the given period.
Bausch Health Cos Annual Change in Accounts Receivable
(Millions of US $) |
| 2024 |
$-216 |
| 2023 |
$-195 |
| 2022 |
$-57 |
| 2021 |
$-229 |
| 2020 |
$170 |
| 2019 |
$39 |
| 2018 |
$216 |
| 2017 |
$417 |
| 2016 |
$-34 |
| 2015 |
$-626 |
| 2014 |
$-572 |
| 2013 |
$-301 |
| 2012 |
$-176 |
| 2011 |
$-165 |
| 2010 |
$25 |
| 2009 |
$-27 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$1.876B |
$9.625B |
|
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
|
